CGEM
Cullinan Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -3.0% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 77 | +7 | 28.05M | $510.52M | +11 | −4 |
| Q1 2026 | 73 | +7 | 24.59M | $348.81M | +10 | −3 |
| Q4 2025 | 65 | +1 | 21.69M | $224.52M | +1 | — |
| Q3 2025 | 17 | +1 | 15.39M | $91.26M | +1 | — |
| Q2 2025 | 13 | 0 | 14.48M | $109.06M | +1 | −1 |
| Q1 2025 | 10 | -1 | 7.69M | $58.25M | — | −1 |
| Q4 2024 | 11 | 0 | 8.98M | $109.41M | — | — |
| Q3 2024 | 10 | +1 | 6.86M | $114.80M | +1 | — |
| Q2 2024 | 9 | — | 7.12M | $124.19M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 4.22M | — | $31.76M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 4.22M | — | $31.76M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 4.22M | — | $31.76M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 4.22M | — | $31.76M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 4.22M | — | $31.76M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 4.22M | — | $31.76M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 4.22M | — | $31.76M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 4.22M | — | $31.76M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 4.22M | — | $31.76M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 4.22M | — | $31.76M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passief) | 3.02M | — | $22.74M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (passief) | 3.02M | — | $22.74M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (passief) | 3.02M | — | $22.74M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passief) | 3.02M | — | $22.74M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passief) | 3.02M | — | $22.74M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 2.61M | -4.9% | $19.68M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 2.61M | -4.9% | $19.68M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | State Street Global Advisors ✦ (passief) | 1.61M | -8.3% | $12.11M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Geode Capital Management ✦ (passief) | 1.28M | +3.0% | $9.64M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Geode Capital Management ✦ (passief) | 1.28M | +3.0% | $9.64M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Marshall Wace ✦ | 626.58K | +10.3% | $4.72M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | Millennium Management ✦ | 510.83K | -34.8% | $3.85M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | Renaissance Technologies ✦ | 334.52K | -7.8% | $2.52M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 24 | Wellington Management ✦ | 186.08K | +15.5% | $1.40M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Wellington Management ✦ | 186.08K | +15.5% | $1.40M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Wellington Management ✦ | 186.08K | +15.5% | $1.40M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | T. Rowe Price ✦ | 36.42K | +14.8% | $275,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | D. E. Shaw & Co. ✦ | 25.33K | -19.6% | $190,727 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 20.92K | Nieuw | $157,528 | 0.0% | New | 1 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 20.92K | Nieuw | $157,528 | 0.0% | New | 1 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 20.92K | Nieuw | $157,528 | 0.0% | New | 1 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 20.92K | Nieuw | $157,528 | 0.0% | New | 1 | SEC ↗ |
| 33 | Fidelity (FMR) ✦ | 3.81K | — | $28,704 | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| AQR Capital Management | $157,528 | 0.0% |
| AQR Capital Management | $157,528 | 0.0% |
| AQR Capital Management | $157,528 | 0.0% |
| AQR Capital Management | $157,528 | 0.0% |
Verlaten
| Two Sigma Investments | $112,006 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 172 houders, 65.27M aandelen, $895.39M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 30.00K aand · $607,800
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie